Abstract Mechanisms underlying production of vascular free radicals are unclear. We hypothesized that changes in blood flow might serve as a physiological stimulus for endothelial free radical release. Intact isolated aortas from 45 rabbits were perfused with the spin trap a-phenyl-N-tertbutylnitrone (PBN, 20 mmol/L) and formed radical adducts detected by electron paramagnetic resonance spectroscopy (EPR). Sequential perfusion at 2, 7.5, and 12 mL/min changed cumulative vascular PBN radical adduct yields, respectively, from 3.2+0.9 to 4.1±0.7 (P<.05) and 7.0±1.5 (P<.005) pmol/mg with endothelium and from 3.6±1.6 to 3.8±1.4 and 2.2±0.8 pmol/mg without endothelium (P=NS). In endothelialized aortas, superoxide dismutase (SOD) completely blocked flow-induced free radical production, whereas inactivated SOD, indomethacin, and the nitric oxide synthetase antagonist nitro-L-arginine methyl ester (L-NAME) had no effect; relaxations to acetylcholine remained unchanged with higher flows. To assess the role of flow on in vivo radical production, femoral arterial plasma levels of the ascorbyl radical, a stable ascorbate oxidation product, were measured by direct EPR in 56 other rabbits. Ascorbyl levels were assessed at baseline (30.2±0.7 nmol/L) and at peak-induced iliac flow changes. Flow increases from 25% to 100% due to saline injections through an extracorporeal aortic loop induced significant dose-dependent increases in ascorbyl levels (n=5). In addition, after papaverine bolus injections, flow increased by 114±8% versus baseline, and ascorbyl levels increased by 5.4±0.7 nmol/L (n=31, P<.001); similar results occurred with adenosine, isoproterenol, or hyperemia after 30-second occlusions (P<.05, n=4 or 5 in each group). Active SOD completely blocked papaverine-induced ascorbyl radical increase, despite preserved flow response (Aascorbyl=0.02±1.6 nmol/L, P=NS); inactivated SOD, catalase, indomethacin, and L-NAME had no effect. Blood flow decreases of 65% to 100% due to phenylephrine or 60-second balloon occlusions were accompanied by an average decrease of 4.4 nmol/L (P<.05) in ascorbyl levels. No change in ascorbyl signal was observed when rabbit blood alone was submitted to in vitro flow increases through a tubing circuit. Thus, increases in blood flow trigger vascular free radical generation; such a response seems to involve endothelium-derived superoxide radicals unrelated to cyclooxygenase or nitric oxide synthetase activities. This mechanism may contribute to explain vascular free radical generation in physiological or pathological circumstances. (Circ Res. 1994;74:700-709.) Key Words * ascorbyl radical * superoxide dismutase * nitric oxide * endothelium * oxidative stress T he identification of the gaseous free radical nitric oxide (QN=O) as a major signal transducer molecule and endothelium-derived vascular relaxing factor1 suggests that oxyreduction reactions are important effector steps for autocrine or paracrine regulation of vessel tone, permeability, and structure in physiological or pathological conditions. Other free radicals, such as oxygen-derived intermediates, may thus be released by blood vessels. The superoxide radical (02. potently inactivates nitric oxide.23 Since CuZn-superoxide dismutase (SOD) administration relaxes precontracted endothelialized arterial rings2,3 and endogenous SOD inhibition attenuates vessel relaxation to acetylcholine,4 it is possible that superoxide radicals
T he identification of the gaseous free radical nitric oxide (QN=O) as a major signal transducer molecule and endothelium-derived vascular relaxing factor1 suggests that oxyreduction reactions are important effector steps for autocrine or paracrine regulation of vessel tone, permeability, and structure in physiological or pathological conditions. Other free radicals, such as oxygen-derived intermediates, may thus be released by blood vessels. The superoxide radical (02. potently inactivates nitric oxide.23 Since CuZn-superoxide dismutase (SOD) administration relaxes precontracted endothelialized arterial rings2,3 and endogenous SOD inhibition attenuates vessel relaxation to acetylcholine,4 it is possible that superoxide radicals may be continuously released by the endothelium. 5 However, available evidence of vascular free radical production is mostly indirect and related to noxious interventions; it is unclear whether intact vessels can generate free radicals under physiological stimuli. For example, we reported previously that SOD administration prevents vasoconstriction after experimental angioplasty.6 Also, SOD attenuates atherosclerotic endothelial dysfunction7 and decreases blood pressure in spontaneously hypertensive rats.8 Previous studies with cultured endothelial cells showed enhanced superoxide production in response to postischemic reperfusion9'10 and several other stimuli1l-14; low-density lipoprotein is oxidized on exposure to cultured endothelial cells. 15 In perfused intact vessels, superoxide production was triggered by the diabetogenic drug alloxan. 16 In in vivo conditions associated with toxic free radical effects, more direct measurements of oxidative stress have been sought through a variety of methods.17'8 Electron paramagnetic resonance spectroscopy (EPR), probably the less ambiguous among such techniques, 18, 19 allowed, for example, in vivo demonstration of free radical release after myocardial ischemia with the use of spin-trap compounds. 20 It is well known that flow can trigger vasoactive responses21 and the production of several endothelium-derived mediators, such as nitric oxide2223 and prostacyclin. 24 We hypothesized that blood flow increase could be a stimulus for endothelial free radical production in intact vessels. In isolated perfused rabbit aortas, we assessed flow-triggered endothelial free radical production through experiments with the spin-trap compound a-phenyl-N-tert-butylnitrone (PBN). In addition, we assessed free radical generation in vivo by measurement of plasma levels of the ascorbyl free radical through direct EPR. The ascorbyl radical (A-) is the rather stable univalent oxidation product of ascorbic acid,25-32 which appears to be the first extracellular defense against oxygen-derived radicals. [33] [34] [35] This method has recently been used as a reliable index of free radical release in synovial inflammation,27 myocardial ischemia,3031 plasma iron overload,32 and paraquat administration. 36 In the present study, we measured ascorbyl radical levels formed from endogenous ascorbic acid during rapid flow variations induced by mechanical or pharmacologic maneuvers.
Materials and Methods Materials
Human recombinant CuZn-SOD was a kind gift from Chiron Corp, Emeryville, Calif. SOD activity, assessed by the method of McCord and Fridovich,37 was 16 986 U/mg protein; there was no loss in activity with storage of diluted enzyme at 4°C to 8°C. SOD was inactivated by modification of the procedures used by Hodgson and Fridovich38; the enzyme was incubated with a 100-fold excess of hydrogen peroxide in phosphate buffer (pH 10.0) for 12 hours at room temperature and then thoroughly dialyzed. This technique resulted in >99% loss of enzyme activity, without apparent protein denaturation. Papaverine and isoproterenol were from the local hospital pharmacy. Commercial deferoxamine mesylate was from CIBA-GEIGY Corp, Basel, Switzerland. All other reagents were obtained from Sigma Chemical Co, St Louis, Mo, stored according to manufacturer's specifications, and dissolved in 0.9% NaCl solution immediately before use. PBN was recrystallized from hexane, since a contaminating triplet radical appeared when the commercially available compound was used. For indomethacin, the pH was adjusted to 9.0 to 9.5 with Na2CO3 at 45°C to 50°C for 30 minutes and then corrected to 7.0 with HCl. Bovine liver catalase (Sigma No. C-10) activity provided by the manufacturer was 4000 U/mg protein.
Protocol 1: Ex Vivo Aortic Perfusion With PBN Preparation
Male New Zealand White rabbits (n=45) were killed with pentobarbital. Their thoracic aortas (6 to 7 cm in length) were immediately excised, thoroughly cleansed of adventitial tissue, and placed free into a closed perfusion chamber (7.0x0.8 cm) connected from both sides to a self-closed tubing circuit with an open reservoir. Flow was provided in the physiological arterial direction by a roller pump (LKB 2115 Multiperpex, H.J. Guldener, Zurich, Switzerland); the priming volume of the system was 6.0 mL. The aortas were perfused with KrebsHenseleit solution of the following composition (mmol/L): NaCl 113.0, KCl 4.7, CaCl2 2.5, NaHCO3 25.0, MgSO4 1.1, KH2PO4 1.1, EDTA 0.03, and glucose 11.0. The solution was kept at 37°C and was bubbled with 95% 02/5% CO2. The lipophilic spin-trap PBN was added immediately before starting arterial perfusion at a final concentration of 20 mmol/L.
Protocol
To test the influence of flow on PBN radical adduct production, flow rate was started at 2 mL/min and maintained for 10 minutes. The first aortic fragment was then collected in liquid nitrogen. The remainder of the vessel was perfused at 7.5 or 12 mL/min for another 10 minutes and then frozen. There were no changes in perfusion pressure with increased flow. Preliminary data showed that a minimum amount of 50 to 60 mg of tissue was needed for analysis, thus allowing collection of up to two or three fragments for each aorta. The effluent was also analyzed but did not show detectable radical adducts.
Vessels were analyzed with (total n=34) or without (n=7) endothelium. The endothelium was removed with a loosely inflated Fogarty balloon catheter (three movements in each direction). In four control experiments, endothelialized aortas were initially perfused as described (2 mL/min for 10 minutes), whereas the second fragment was perfused at 2 mL/min for 60 minutes. This group was designed to match the same number of fluid cycles provided by a 12 mL/min flow for 10 minutes. In all these groups, oxygen bubbling was rigorously kept in similar conditions.
For investigation of mechanisms of free radical generation, putative antagonists were added to the reservoir immediately before starting perfusion of endothelialized aortas, and flow variation (from 2 to 12 mL/min) was performed as described. The following agents were tested: (1) human recombinant CuZn-SOD (100 ,g/mL, n=4), (2) inactivated human recombinant SOD (100 ,ug/mL, n=3), (3) indomethacin (10-5 mol/L, n=6), and (4) nitro-L-arginine methyl ester (L-NAME, a competitive inhibitor of nitric oxide synthetase,' 10`' mol/L, n=5). With indomethacin, the first period of perfusion at 2 mL/min was 30 minutes, to allow complete cyclooxygenase blockade.
Analysis of PBN Radical Adducts
Arterial fragments were kept at -80°C until analysis. On thawing, they were homogenized in phosphate-buffered saline (PBS) with a Biospec tissue homogenizer (model M133/ 1281-0, BiospecProducts Inc, Bartlesville, Okla) for 20 seconds. The lipid fraction was extracted through a modified Folch's procedure (Bolli et a120) without use of methanol, since preliminary experiments showed a methanol-derived contaminating radical. Also, a few initial experiments disclosed a contaminating triplet radical, which was not found after PBN recrystallization. Those samples were included in the analysis, since measurements were clear and showed results similar to others. EPR analysis of lipid extracts was performed in a spectrometer (model ER-200D SRC, Bruker Analytische Messtechnik GmBH, Germany). The EPR spectra were run in chloroform, after bubbling gaseous nitrogen for 30 seconds. PBN adducts were quantified by double integration of their respective EPR signals using TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl) as a standard.39
In Vitro Vascular Contractility Arterial rings were mounted in an organ bath with oxygenated Krebs-Henseleit solution at 37°C and allowed to equilibrate for 1 hour under a 2-g preload, according to previously described techniques.40 Tension was continuously recorded by an F-60 microdisplacement myograph (Narco Biosystems Inc, Houston, Tex). Rings were precontracted with 10-7 mol/L norepinephrine; cumulative concentration-effect curves to acetylcholine (10`to 10`6 mol/L) were constructed in the presence or absence of endothelium, which was removed mechanically. Rings were collected as follows: after dissection (before perfusion), at the end of first perfusion period (low flow rate), and at the end of second perfusion period (high flow rate). In some endothelialized rings, SOD (100 ,ug/mL), L-NAME (10`mol/L), or indomethacin (10-5 mol/L) was added to the organ bath before the norepinephrine-induced contraction. night in 0.1N HCl, as reported previously by Buettner and Chamulitrat.26, 27 Arterial blood (1.5 mL) was carefully collected to avoid induction of arterial flow changes and handled in a way to prevent hemolysis; separated plasma was immediately frozen in liquid nitrogen and kept at -80°C until further analysis. Preliminary experiments showed that presence of visible hemolysis was associated with poor ascorbyl signals, possibly because of released hemoglobin. Immediately after thawing, a 200-,L plasma sample was transferred to a flat quartz cell for direct EPR analysis of ascorbyl radicals. Ascorbyl radical concentration was derived from measurement of the peak height of high-field peak of its characteristic spectrum, with the hyperfine splitting constant aH=0.186 mT, shown in Fig 6, in relation to the height of the central peak of the spectrum obtained from a solution with a known concentration of the stable free radical 3-carboxy-proxyl (3-carboxy-2,2,5,5-tetramethyl-L-pyrrolidine-N-oxyl).26 Also, in accordance with previous reports for human plasma,28'32 no ascorbyl radical decay was observed in rabbit plasma for up to 2 hours. Preliminary data also showed no influence of freezing on plasma ascorbyl levels.
Basic Preparation
Male New Zealand White rabbits weighing 2.4 to 3.1 kg were anesthetized with sodium pentobarbital (20 to 25 mg/kg IV) and maintained on spontaneous respiration with supplemented 02. Blood gases and arterial pH were kept within physiological limits. Additional pentobarbital was given when needed as 3-to 5-mg/kg boluses. The left carotid artery was cannulated and connected to a fluid-filled pressure transducer (model 1280, Hewlett-Packard Co, Palo Alto, Calif). A polyethylene catheter, for blood collection, was advanced into a branch of the right femoral artery 2 to 3 cm upward. Catheters were flushed with 0.9% NaCl solution with 10 IU/mL heparin.
Dose-Response Curve With an Extracorporeal Aortic Loop
The aim of this protocol was to assess the effects of progressive well-defined flow increases on ascorbyl levels. In these rabbits, the abdomen was opened longitudinally, and a 3-cm segment of aorta was isolated below the emergence of renal arteries; an intravenous heparin bolus (250 mg/kg) was given. After the aorta was tied, a Y-shaped plastic tube system (outer diameter, 2.5 mm; total length, 22 cm) was quickly inserted into vessel lumen, with one branch downward to the suture and one branch upward; the third branch was connected to a pressurized reservoir of PBS,25 pH 7.4, previously treated with the iron-chelating resin iminodiacetic acid (Chelex). Thus, an extracorporeal looping circuit (18 to 19 cm in length) was allowed; a tubular extracorporeal electromagnetic flow probe (2.0 mm in internal diameter) was inserted into the distal branch of the loop and connected to a flowmeter (model SP2201, Statham Medical Division, Oxnard, Calif). Arterial pressure distal to the circuit was monitored through a left femoral catheter. Flow increases of 25%, 50%, 75%, or 100% versus respective baseline values were induced in each of five rabbits through short PBS infusions obtained by controlled opening of a valve in the pressurized PBS reservoir circuit. Each increase in flow was maintained at stable levels for 60 seconds and separated by a 15-minute interval; right femoral blood samples were collected at each baseline, between 40 and 60 seconds after starting higher flows, and 14 minutes after stopping PBS infusions. To correct for the hemodilution induced by PBS, ascorbyl radical levels were normalized for plasma protein content, which was measured in each sample through the biuret reagent; results were expressed in nanomoles per liter per gram per deciliter.
Iliac Artery Flow Changes and Ascorbyl Production
The aim of these experiments was to assess plasma ascorbyl radical generation accompanying rapid iliac flow increases or decreases induced by bolus injections of chemically distinct vasoactive compounds, by hyperemia after short occlusions, or by balloon-induced occlusions. In 51 rabbits, after the basic preparation described above, another polyethylene catheter, for drug administration, was advanced through the left femoral artery until it was 0.5 to 1 cm above the iliac bifurcation, as verified by digital palpation after the abdomen was open. The origin of the right iliac artery was isolated through a small hypogastric incision; an electromagnetic flow probe (2.0 mm in diameter) was placed. Systemic arterial pressure and mean right iliac blood flow were continuously monitored through a recorder (model 8890-A, Hewlett-Packard). Right femoral arterial blood was collected for ascorbyl levels at baseline, at peak-induced flow changes, and 15 minutes after the drug injection or snare release. In some rabbits, blood was simultaneously collected from the right femoral vein through a Tygon catheter. All bolus doses of drugs were administered while a 3.82-mL/min flow of heparinized saline was provided by an infusion pump (Harvard Apparatus, South Natick, Mass) to maximize reproducibility. Doses of vasodilator drugs were designed to approximately double baseline flow, in accordance with previous results of the dose-response curve; also, higher doses induced more pronounced decrease in arterial pressure, thus limiting flow increase. For all interventions, blood flow reached its maximal change 15 to 30 seconds after the start and returned to near-baseline values 50 to 100 seconds later. Preliminary studies showed that ascorbyl plasma levels returned toward baseline 2 to 3 minutes after interventions.
Blood flow increases were induced by (1) papaverine (2 to 5 mg, n=31; this number included all papaverine injections administered as controls before the blocking agents described below), (2) isoproterenol (0.5 mg, n=4), (3) adenosine (0.5 mg, n=5), and (4) reactive hyperemia, after release of a 30-second snare-induced total occlusion (n=5). Blood flow decreases were induced by (1) phenylephrine (6.4 ,ug, n=5) and (2) mechanical occlusion, induced by an aortic 2F Fogarty balloon catheter (Edwards Laboratory, Santa Ana, Calif) for 60 seconds (n=4). Blood was collected between 40 and 60 seconds of occlusion. A total of one to three treatments were performed in each rabbit; repeated papaverine bolus injections in eight rabbits showed reproducibility of ascorbyl radical changes.
For investigation of some putative mechanisms involved in free radical release, a first control papaverine bolus was followed by a second bolus on top or after an antagonist, and ascorbyl plasma levels were similarly assessed; only one agent was tested per rabbit. SOD, catalase, or L-NAME was given as an infusion, adjusted to the rate of 3.82 mL/min; indomethacin was administered as a 15-minute infusion, terminating 30 minutes before repeated papaverine bolus doses. The doses of those agents were as follows: (1) 5.0 mg/kg human recombinant CuZn-SOD (3.1 mg/kg for 5 minutes before papaverine and 1.9 mg/kg for 3 minutes thereafter), n=9; (2) 5.0 mg/kg catalase (3.1 mg/kg for 5 minutes before papaverine and 1.9 mg/kg for 3 minutes thereafter), n=5; (3) 5 mg/kg indomethacin, n=4; and (4) 20 mg/kg L-NAME (17 mg/kg for 17 minutes before papaverine and 3 mg/kg for 3 minutes thereafter), n=5. Choice of doses for these drugs was based on previous in vivo studies showing their effect in postangioplasty vasospasm6 or myocardial ischemia.41 L-NAME effect was confirmed by the induced rise in arterial pressure.
Perfusion of Rabbit Blood Through an In Vitro Tubing Circuit
To assess whether submitting blood alone to flow changes would affect ascorbyl radical production, 60 mL of blood was slowly collected from two anesthetized rabbits given 250 IU/kg heparin. The syringe was immediately placed into a Harvard infusion pump and connected to a coiled polyethylene tubing circuit (300 cm in length, 2.0 mm in internal diameter) immersed in a water bath kept at 37°C. Plasma ascorbyl levels, pH, and Po2 were assessed (1) before blood collection, (2) 7 .5 or 12 mL/min in the same specimens induced production of free radicals in endothelialized aortas, as indicated by the well-defined EPR spectra obtained (Fig  1) . The parameters of such a spectrum (hyperfine splitting constants aN=1.46 mT and aH=0.27 mT) indicate trapping of a lipid-derived free radical.20 In endothelium-denuded aortas, no enhancement in detectable signals was observed; rather, there was a tendency toward decreased radical production with higher flows, which was possibly due to loss of radical adducts through diffusion and/or decomposition. Fig 2 depicts the changes in PBN radical adduct yields for these conditions; with intact endothelium, the respective values for perfusion rates of 2, 7.5, and 12 mL/min were 3.2+0.9, 4.1±0.7 (P<.05 versus 2 mL/min), and 7.0± 1.5 (P<.005 versus 2 mL/min) pmol/mg. Corresponding values for deendothelialized aortas were 3.6+1.6, 3.8+1.4, and 2.2±0.8 pmol/mg (p=NS). PBN alone produced no EPR spectra. In other control experiments (n=4), endothelialized aortas perfused for 2 mL/min for 10 minutes and then for 2 mL/min for 60 minutes showed a small decrease in free radical production from 4.1±0.6 to 2.6±0.5 pmol/mg (p=NS). Fig 3 shows the effects of SOD, indomethacin, and L-NAME on flow-triggered free radical production in endothelialized aortas. Indomethacin had no effect. s~rk   FIG 1. a-Phenyl-N-tert- L-NAME partially blunted this response, but free radical increase was still significant and not statistically different compared with the control value. Active SOD completely inhibited free radical production; this blocking effect was not observed with the inactivated enzyme (data not shown, n=3). Taken together, these results suggest that the lipid-derived radical trapped with PBN (Fig 1) is a product of superoxide generation in response to flow changes. Indeed, superoxide radicals can induce lipid peroxidation, forming radicals that give stable PBN radical adducts,18-20 whereas both PBNsuperoxide and PBN-hydroxyl radical adducts are too unstable to be detected in most experimental conditions.42 In Vitro Vascular Reactivity to Acetylcholine Fig 4 shows concentration-effect curves produced by acetylcholine in endothelialized rings from rabbit aorta. In relation to control (nonperfused) rings, vessels perfused at 2 mL/min for 10 minutes showed a slight decrease in relaxation but were identical to those further perfused at 12 mL/min for 10 minutes. Thus, flow-triggered free radical production was not a result of mechanically induced endothelial lesion in this model. Graph showing the concentration of a-phenyl-N-tertbutyinitrone (PBN) radical adducts in lipid extracts of fragments of isolated aortas (n=21) removed after sequential cumulative perfusion at 2, 7.5, and 12 mL/min for 10 minutes each period. The respective numbers of samples for each flow were 14, 8, and 11 for endothelialized aortas (ENDOTH +) and 7, 3, and 7 for aortas without endothelium (ENDOTH -). In eight rabbits, perfusion with those three flows was achieved; in the remainder, perfusion was started at 2 mL/min and increased either to 7.5 orFIG 3. Bar graph depicting flow-related increases in a-phenyl-N-tert-butyinitrone (PBN) radical adduct yields in endothelialized aortas in the control condition and after treatment with superoxide dismutase (SOD, n=4), indomethacin (IND, n=6), or nitro-L-arginine methyl ester (L-NA, n=5). Active SOD completely blocked radical generation, whereas other treatments were ineffective. *P<.02 vs baseline. Statistical analysis across groups (ANOVA and Student-Newman-Keuls test) showed that the SOD group was different from the control or IND groups (P<.05) and the L-NA group (P=.06). The L-NA group was not different from the control group. Data are mean±SEM.
Mechanical removal of the endothelium was accompanied by the expected decrease in relaxation to acetylcholine, whereas contraction to norepinephrine was 10% to 20% above the control level. Indomethacin and SOD induced no change in vessel reactivity compared with the control value. Rings taken from aortas after perfusion with L-NAME in the chamber showed markedly inhibited relaxations to acetylcholine (data not shown, n=4), with maximal relaxation depressed at least by 50% compared with the control value; this depression was similar to that of control rings without perfusion in which 10-4 mol/L L-NAME was added before acetylcholine.
Protocol 2: In Vivo Ascorbyl Radical Measurements
In these experiments, blood flow changes were induced in vivo by several maneuvers, and free radical generation was assessed through direct EPR measurement of plasma levels of the ascorbyl free radical. First, a dose-response curve was obtained in 5 rabbits after flow changes induced by controlled PBS injections through an extracorporeal aortic looping circuit. In 51 other rabbits, further characterization of free radical release was performed after flow changes induced pharmacologically, in ison with simultaneously collected samples without deferoxamine. Also, ascorbyl levels were not modified by in vitro addition of SOD (100 ,g/mL). Ascorbyl radical levels in venous plasma samples (n=9), collected simultaneously with arterial plasma during papaverine challenges, showed close values and a similar behavior, but the changes were blunted by >50%. Effects of SOD, Catalase, Indomethacin, and L-NAME Treatment with SOD induced no changes in arterial pressure. Indomethacin and L-NAME induced sus-26±4 (P<.01) mm Hg versus baseline, tained increases in arterial pressure of 15±3 and 15±3 vcompanying the peak flow effects. Phenmm Hg, respectively (P<.01 for both). The peak perced a transient small (<10 mm Hg) incent decrement in arterial pressure with papaverine rial pressure, whereas balloon-induced after each of those three treatments was similar to that lusions and reactive hyperemia after 30-observed before any treatment. ons induced no change.
As shown in Fig 8, ascorbyl radical release during papaverine-induced flow increase was completely prexal Plasma Levels vented by SOD but not by catalase, indomethacin, or ues of ascorbyl radical plasma levels were L-NAME. In two experiments, inactivated SOD (12.5 l/L and did not differ among groups. mg) had no effect on papaverine-induced increases in baseline levels for each group were as blood flow and ascorbyl radical levels. None of these 
Discussion
The present study provides direct in vivo and ex vivo evidence for a novel mechanism accounting for free radical release in intact vessels, namely, increases in blood flow. Data from our isolated vessel preparation detected in both directions around baseline autoregulated flow. Superoxide radical accounted for the major component of flow-related free radical generation, as evidenced by the inhibitory effect of SOD in both preparations; superoxide release appeared independent of cyclooxygenase and nitric oxide synthetase activities, since neither indomethacin nor L-NAME affected free radical production.
Methodological Considerations
The PBN radical adduct triggered by flow increases showed a spectrum suggesting the trapping of a lipidderived free radical; this adduct is similar to the one detected by Bolli and colleagues20'4' after myocardial ischemia and reperfusion. Recently, some concerns have been raised about the influence of high spin-trap 1 2 9 * 0 6 <3 0 concentrations in toxic phenomena, eg, in the myocardium43; a vasodilator effect of spin traps has also been reported in the isolated perfused heart.43 Thus, PBN could affect the preparation by inducing free radical spectra secondary to its own toxic effect. To account for this possibility, control deendothelialized arteries and endothelialized arteries perfused at low flows were exposed to the same PBN concentrations and showed no adduct production. Furthermore, Fig 4 shows that the relaxation of rings exposed to PBN after perfusions at 2 and 12 mL/min was well preserved, with no evidence of toxic endothelial effects. Since the flowdependent increase in EPR signals was completely abolished by SOD, it is suggested that superoxide is the primary radical triggered by flow increases and that the resulting free radical adduct is a product of the reaction It is well known that cultured endothelial cells are important sources of oxygen-derived intermediates in response to redox-cycling compounds,'1 cytokines,12 bradykinin,13 paraquat administration,14 and postischemic reperfusion.9"10 In both our preparations, the increase in free radical signals probably reflects extracellular superoxide radical release, since this increase was abolished by native SOD; this enzyme is a specific superoxide scavenger51 that does not cross intact endothelial membranes or intercellular junctions.8'52 Contrary to cultured endothelium, endothelial cells from intact vessels, because of matrix-bound scavengers such as extracellular SOD53 and other factors, might exhibit polarization of free radical release, with predominance of nitric oxide at the abluminal side and a higher superoxide/nitric oxide proportion at the luminal side. This is suggested by reports of distinct luminal and abluminal production of endothelium-derived relaxing factor.54 Also, constitutive or exogenous matrix-bound SOD was more effective than native enzyme in attenuating oxidant-induced endothelial injury55 and experimental hypertension.8 Thus, the observed free radical production in plasma may not correspond to a similar abluminal release.
Involvement of Cyclooxygenase and Nitric Oxide Synthetase in Vascular Free Radical Production
Cyclooxygenase activity was not responsible for detectable free radical production in both our models. Thus, flow-dependent free radical release appears unrelated to synthesis of the vasodilator prostacyclin, which is released from the endothelium in a flowdependent manner,24 or to the effect of vasoconstrictor prostaglandin H2, which depends on endothelial superoxide release.56 Previous reports of vasoactive superoxide effects in brain showed its relation with the activity of prostaglandin endoperoxide synthetase.57'58 On the other hand, superoxide radicals can mediate direct cyclooxygenase-independent arachidonate oxidation, releasing vasoconstrictor prostaglandins. 59 Generation of free radical intermediates during L-arginine oxidation has been suggested previously,' although it is not clear whether they are necessary for nitric oxide synthesis. Recently, Pou et a160 provided in vitro EPR evidence for superoxide production by purified brain nitric oxide synthetase in the absence of L-arginine; superoxide signals were abolished by L-NAME. However, the lack of effect of high-dose L-NAME, both in vivo and ex vivo, in the present study argues against a direct role of nitric oxide synthetase in flow-triggered free radical generation. The mild L-NAME blocking effect in our ex vivo preparation is probably nonspecific. 61, 62 Implications In contrast to previously sought mechanisms, flowdependent free radical release in intact vessels may explain free radical generation not only in pathological circumstances but also physiologically. The known effects of both flow and oxidative stress on endothelial permeability,48'63 pHi,64,65 and cytosolic [Ca2+149 are consistent with an autocrine regulatory role for flow-related free radical production. Furthermore, the observed free radical changes in both directions around baseline flow are consistent with their paracrine role in flow autoregulation. Finally, our findings may clarify some aspects of superoxide-dependent vasoconstriction after angioplasty6 and oxidant stress-related endothelial dysfunction associated with atherosclerosis,7 diabetes,66 and hypertension.8 '40 In general, our results are consistent with and further expand the concept of oxygen-derived free radical production as a physiological event that may be beneficial.67 Accordingly, vascular or endothelial oxidative damage may arise not only when free radical production is excessive but also at its normal levels, if not buffered by efficient and accessible defense systems.
